Ciprofloxacin/dexamethasone is a prescription ear drop that pairs a fluoroquinolone antibiotic with a corticosteroid, and it has become one of the most widely used topical treatments for ear infections involving the outer ear canal and the middle ear. Sold under the brand name Ciprodex, the combination treats two problems at once: the bacterial infection itself and the painful inflammation that comes with it. The evidence behind this combination is surprisingly robust for a topical product, with multiple randomized trials showing it outperforms older alternatives and even oral antibiotics in certain situations.
How the Two Ingredients Work Together
Ciprofloxacin, the antibiotic half of the combination, belongs to the fluoroquinolone class and kills bacteria by interfering with the enzymes they need to copy and repair their DNA. At the concentration delivered in these drops (0.3%, or 3,000 micrograms per milliliter), the drug far exceeds the minimum concentration needed to kill virtually all the bacteria commonly found in ear infections.1PubMed. Ciprofloxacin 0.3%/dexamethasone 0.1% topical drops for the management of otic infections That matters because topical delivery puts the drug right at the site of infection in concentrations that oral antibiotics could never safely achieve in the bloodstream.
Dexamethasone, the steroid component at 0.1%, tamps down inflammation. Swelling, redness, and fluid accumulation in the ear canal are not just side effects of infection; they cause most of the pain. Animal studies have shown that dexamethasone-treated ears cleared inflammatory fluid significantly better than untreated controls.2JAMA Otolaryngology–Head & Neck Surgery. Steroid Control of Acute Middle Ear Inflammation in a Mouse Model Clinically, the combination of both drugs outperforms ciprofloxacin alone, cutting the average time to stop ear drainage from about five and a half days to about four days in children with ear tube infections.3The Laryngoscope. Topical Ciprofloxacin/Dexamethasone is Superior to Ciprofloxacin Alone in Pediatric Patients with Acute Otitis Media and Otorrhea through Tympanostomy Tubes That one-day difference might sound modest, but for a child (and their parents) dealing with persistent ear discharge, it represents a roughly 20% faster resolution.
Swimmer’s Ear and Outer Ear Infections
Otitis externa, commonly called swimmer’s ear, is one of the two main conditions this combination treats. The ear canal becomes infected and swollen, and the pain can be intense. In a head-to-head trial against the older standard treatment of neomycin/polymyxin B/hydrocortisone (the generic triple-antibiotic steroid drops), ciprofloxacin/dexamethasone produced significantly faster pain relief. Patients on the combination saw severe pain drop rapidly within the first 12 hours, while those on the older drops actually experienced a temporary increase in pain during that same window.4PubMed. A comparison of ciprofloxacin/dexamethasone with neomycin/polymyxin/hydrocortisone for otitis externa pain That initial spike with neomycin-based drops is likely due to their acidity and the irritating effect of aminoglycoside antibiotics on inflamed tissue.
Beyond pain, the clinical cure rates tell a similar story. In a randomized trial of nearly 400 culture-positive patients with otitis externa, about 91% of those treated with ciprofloxacin/dexamethasone were clinically cured by day 18, compared with about 84% on the neomycin-based drops. Bacterial eradication rates were also higher, at roughly 95% versus 86%.5PubMed. Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa Both adults and children tolerated either treatment well, so the choice between them comes down to effectiveness and, as discussed below, safety when the eardrum might not be intact.
Ear Tube Drainage in Children
The other major use for ciprofloxacin/dexamethasone is treating drainage that comes through tympanostomy tubes, the tiny tubes placed in children’s eardrums to manage recurrent middle ear infections. When bacteria get into the middle ear of a child with tubes, infected fluid drains out through the tube rather than building up behind the eardrum. This condition, called acute otitis media with otorrhea through tympanostomy tubes, has been studied more thoroughly with this combination than with almost any other topical ear treatment.
Compared with oral amoxicillin/clavulanate (the go-to oral antibiotic for ear infections), topical ciprofloxacin/dexamethasone cut the median time to stop drainage nearly in half: four days versus seven. Clinical cure rates were also substantially better at about 85% versus 59%, and the topical drops produced fewer side effects than the oral antibiotic.6Pediatrics. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes This finding was important because it helped shift clinical practice away from reflexively prescribing oral antibiotics for tube drainage, since the topical route gets much higher drug concentrations directly to the infection with virtually no systemic exposure.
When compared with ofloxacin, another fluoroquinolone ear drop that was already on the market, ciprofloxacin/dexamethasone again came out ahead. Clinical cure rates were about 90% versus 78%, and the median time to cessation of otorrhea was four days versus six. Treatment failures were also less common at roughly 4% versus 14%.7PubMed. Clinical trial comparing ciprofloxacin/dexamethasone and ofloxacin in acute otitis media with otorrhea through tympanostomy tubes The key advantage over ofloxacin appears to be the dexamethasone component, since ofloxacin drops contain no steroid. That anti-inflammatory effect does not just reduce symptoms; it also helps resolve the granulation tissue that sometimes forms around tympanostomy tubes during active infection. In a dedicated analysis, ciprofloxacin/dexamethasone resolved granulation tissue in about 92% of cases by the end of treatment, compared with about 73% for ofloxacin alone.8Otolaryngology–Head and Neck Surgery. Topical Ciprofloxacin/Dexamethasone Otic Suspension is Superior to Ofloxacin Otic Solution in the Treatment of Granulation Tissue in Children with Acute Otitis Media With Otorrhea Through Tympanostomy Tubes Granulation tissue can block the tube and cause ongoing problems, so this is a practical benefit beyond infection clearance.
Why the Ototoxicity Profile Matters
One of the most important reasons clinicians choose ciprofloxacin/dexamethasone over older alternatives has nothing to do with efficacy and everything to do with safety for the inner ear. When the eardrum has a hole in it, whether from a perforation, a tympanostomy tube, or surgery, whatever you put in the ear canal can reach the middle ear and potentially the delicate structures of the inner ear. Aminoglycoside antibiotics like neomycin and gentamicin are known to be toxic to the hair cells of the cochlea, the cells responsible for hearing. Using neomycin-containing drops through a perforated eardrum is generally considered risky.
Fluoroquinolones, by contrast, have a clean safety record in this regard. In a controlled guinea pig study, ciprofloxacin alone and ciprofloxacin combined with dexamethasone caused no measurable hearing loss and no damage to the organ of Corti after up to four weeks of middle ear exposure. Neomycin, used as a positive control in the same study, produced significant hearing threshold elevation and profound hair cell loss.9JAMA Otolaryngology–Head & Neck Surgery. Safety of Ciprofloxacin and Dexamethasone in the Guinea Pig Middle Ear This is why expert reviews have recommended fluoroquinolone-based ear drops as first-line treatment whenever the eardrum is not intact.10PubMed. Ciprofloxacin 0.3% + dexamethasone 0.1% for the treatment for otitis media
If your eardrum is intact and you have a straightforward case of swimmer’s ear, the ototoxicity question is largely academic since the drops stay in the canal. But if there is any question about whether the eardrum has a perforation, or if you have tubes, the fluoroquinolone option is the safer bet by a wide margin.
The Steroid’s Effect on Eardrum Healing
Dexamethasone brings clear benefits for pain, inflammation, and granulation tissue, but it comes with a trade-off that clinicians need to be aware of. Steroids suppress the inflammatory and proliferative processes that the body uses to repair tissue, and that includes repairing holes in the tympanic membrane. In a chinchilla model, ears treated with ciprofloxacin plus dexamethasone were significantly less likely to heal a perforation within four weeks compared with ears treated with ciprofloxacin alone. About two-thirds of the combination-treated eardrums still had open perforations at four weeks, versus about a quarter of those on ciprofloxacin alone. The steroid increased the odds of persistent perforation more than fivefold.11PubMed. Topical dexamethasone and tympanic membrane perforation healing in otitis media: a short-term study
A separate animal study found a similar pattern: dexamethasone-containing drops significantly delayed tympanic membrane healing compared with controls by around day 10 after perforation. The reassuring finding from that study, however, was that all perforations eventually healed by day 20, suggesting the delay was temporary rather than permanent.12PubMed. Effects of Ciprofloxacin/Dexamethasone and Ofloxacin on Tympanic Membrane Perforation Healing The practical takeaway is that in situations where a perforation needs to close, such as after tube extrusion or a traumatic rupture, the steroid component might slow that process. Clinicians sometimes weigh this when deciding between a fluoroquinolone-only drop and the combination product.
Getting the Drops to the Right Place
A surprisingly common problem with ear drops of any kind is that they do not always reach the middle ear even when there is a tube or perforation to pass through. Surface tension, air bubbles, and the narrow diameter of tympanostomy tubes can all prevent drops from getting past the eardrum. A technique called tragal pumping, where you press the small flap of cartilage in front of the ear canal several times after instilling the drops, can make a meaningful difference.
In a randomized controlled trial, middle ear penetration of ear drops through patent tubes occurred in about 75% of ears when tragal pumping was used, compared with only 33% without it.13PubMed. Assessing the efficacy of tragal pumping: a randomized controlled trial A follow-up study in a rat model with tympanostomy tubes confirmed the effect, showing significantly greater dye penetration into the middle ear after pumping.14PubMed Central. Assessing the Efficacy of Tragal Pumping in a Novel Tympanostomy Tube-Rat Model If you or your child has been prescribed ciprofloxacin/dexamethasone for tube-related drainage, gently pressing the tragus a few times after putting the drops in is a simple way to improve how well the medication works.
Cost and Access
Ciprofloxacin/dexamethasone is not cheap, and cost is a real consideration, especially for families managing recurrent ear problems in children. An economic analysis comparing it with ofloxacin drops for tube-related ear infections found that the combination remained cost-effective as long as its price stayed below roughly four and a half times the wholesale cost of ofloxacin. At actual pharmacy prices, the analysis estimated a threshold of about $153 before the combination lost its economic advantage.15PubMed. A cost threshold analysis of ciprofloxacin-dexamethasone versus ofloxacin for acute otitis media in pediatric patients with tympanostomy tubes That analysis was published years ago, and drug prices have shifted considerably since then.
A more recent economic decision analysis looking at prophylactic use of drops to prevent tube-related ear drainage found that ciprofloxacin/dexamethasone, at around $72, was the cheapest antibiotic/steroid combination available for that purpose and was cost-effective when the risk of otorrhea was at least 10%.16OTO Open. Cost‐Effectiveness of Topical Prophylaxis Against Tympanostomy Tube Otorrhea: An Economic Decision Analysis Generic versions have become available in some markets, which has helped bring prices down, but depending on your insurance coverage the out-of-pocket cost can still be noticeable.
Where the Drops Fall Short
It would be a mistake to assume ciprofloxacin/dexamethasone is a universal solution for all ear infections. The clinical trials showing strong results involved acute infections, relatively short courses, and populations where the underlying ear anatomy was either intact or had a clean surgical tube in place. Chronic suppurative otitis media, a condition involving persistent drainage through a perforated eardrum often lasting weeks or months, is a much harder problem.
A randomized trial in Australian Aboriginal children with recently treated chronic suppurative otitis media found that ear discharge failed to resolve in 70% of children regardless of whether they received ciprofloxacin or a different antibiotic-steroid combination. Tympanic membrane healing occurred in only one of 50 children in the ciprofloxacin group and none in the comparator group. More than half the children in each group showed no improvement in discharge severity, and hearing levels remained essentially unchanged.17The Pediatric Infectious Disease Journal. Topical Ciprofloxin Versus Topical Framycetin-Gramicidin-Dexamethasone in Australian Aboriginal Children With Recently Treated Chronic Suppurative Otitis Media Chronic suppurative otitis media involves biofilm formation, mucosal changes, and sometimes bony erosion that topical drops alone cannot address. When ear drainage persists for more than a few weeks despite appropriate drops, that is typically a signal for specialist evaluation rather than another course of the same medication.
Emerging Uses Beyond the Ear
Clinicians have started exploring ciprofloxacin/dexamethasone in areas outside its original approval. One example is nebulized Ciprodex for managing the airway after tracheal resection surgery, where granulation tissue at the surgical site can narrow the airway and cause complications. A retrospective review of 73 patients who underwent tracheal resection found that about 73% received nebulized Ciprodex during their postoperative care, and side effects were rare: only one patient reported a skin rash and allergic reaction.18The Laryngoscope. Safety of Nebulized Ciprodex for Postoperative Management of Tracheal Resection The rationale is the same anti-granulation effect seen in the ear tube studies, repurposed for a different mucosal surface. Whether this actually improves outcomes compared with other post-surgical airway management remains an open question, but the safety data so far look reassuring.
Separately, researchers have explored sustained-release formulations that would deliver ciprofloxacin to the middle ear over days to weeks from a single application, rather than requiring twice-daily drops. One such product, a hydrogel placed directly in the middle ear, demonstrated drug release lasting up to about two weeks in preclinical testing, in contrast to the brief, pulsatile exposure seen with conventional drops.19PubMed Central. OTO-201: nonclinical assessment of a sustained-release ciprofloxacin hydrogel for the treatment of otitis media A single-dose middle ear treatment applied by the surgeon at the time of tube placement would eliminate the compliance challenge entirely, which is a real issue when you are asking a toddler to hold still for ear drops twice a day for a week. Whether these sustained-release formulations reach the market will depend on clinical trial results, but the concept addresses one of the genuine weak points of the current drops.